Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ALK-Abelló A/S
With
Ergomed
ACM Pivotal Global Central Laboratory
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A clinical relevant history consistent with house dust mite induced asthma of at least 1 year prior to trial entry.
Use of an appropriate amount of inhaled corticosteroid for the control of asthma symptoms.
Documented reversible airway obstruction.
Suitable level of asthma control.
FEV1 ≥ 70% of predicted value.
Positive Skin Prick Test response to Der pte and/or Der far.
Positive specific IgE against Der pte and/or Der far (≥ IgE Class 2; ≥ 0.70 KU/L).
You may not be if
A clinical history of persistent allergic asthma or rhinitis caused by an allergen to which the subject is regularly exposed and sensitised (except house dust mites).
A clinical history of intermittent allergic asthma or rhinitis if the seasonal allergen is causing symptoms in the period from October to March.
Any clinically relevant chronic disease.
Clareo Health | House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
